Mandiri Herindo Adiperkasa Tbk. vs Hetzer Medical Indonesia Tbk. — how do they compare? Mandiri Herindo Adiperkasa Tbk. trades at Rp145 (market cap 2.42T, 4.28M 24h volume), while Hetzer Medical Indonesia Tbk. trades at Rp86 (market cap 139.06B, 51.66M 24h volume). The key difference: Mandiri Herindo Adiperkasa Tbk. is far larger — about 17.4× Hetzer Medical Indonesia Tbk.'s market cap, and Hetzer Medical Indonesia Tbk. is more actively traded (51.66M versus 4.28M). Which is the better fit depends on your goals.
| MAHA | MEDS | |
|---|---|---|
Market Cap | 2.42T | 139.06B |
Volume | 4.28M | 51.66M |
Lot | 42.79K | 516.62K |
Turnover | 613.55M | 4.44B |
Average Price | 143.4 | 85.97 |
Value | 613.55M | 4.44B |
Indicative Equilibrium Price | 145 | 86 |
Indicative Equilibrium Volume | 48 | 9.62K |
Trailing returns across standard periods
Latest headlines on both assets
PT Mandiri Herindo Adiperkasa Tbk. (the Company) is a limited liability company established in the Republic of Indonesia based on Notarial Deed of Julia Rochana Murat, S.H., No. 18 dated January 25, 1994. The Company started commercial activities in 1994.
Read more on MAHA →PT Hetzer Medical Indonesia Tbk (the Company) was established based on Notarial Deed of Cahya Suryana, S.H., Notary in Bandung, No. 12 dated December 31, 2010.
Read more on MEDS →